Comparison of Chimerism and Minimal Residual Disease Monitoring for Relapse Prediction After Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2014.05.026
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Clearance of Minimal Residual Disease After Allogeneic Stem Cell Transplantation and the Prediction of the Clinical Outcome of Adult Patients With High-Risk Acute Lymphoblastic Leukemia

Haematologica
Hematology
2007English

Prophylaxis and Treatment of Acute Lymphoblastic Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

OncoTargets and Therapy
OncologyPharmacology
2015English

Chimerism and Minimal Residual Disease Monitoring After Reduced Intensity Conditioning (RIC) Allogeneic Transplantation

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Extramedullary Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Preventing Relapse After Haematopoietic Stem Cell Transplantation for Acute Leukaemia: The Role of Post-Transplantation Minimal Residual Disease (MRD) Monitoring and MRD-directed Intervention

British Journal of Haematology
Hematology
2017English

The Significance of Graft-Versus-Host Disease and Pretransplantation Minimal Residual Disease Status to Outcome After Allogeneic Stem Cell Transplantation in Patients With Acute Lymphoblastic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2001English

Relapse After Allogeneic Stem Cell Transplantation

Expert Review of Hematology
Hematology
2010English

Chimerism Versus Minimal Residual Disease Monitoring After Allogeneic Transplantation—When Do We Act and Will Intervention Improve Outcomes?

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy